Role of immune cell OGR1 in prostate cancer development and the mechanisms involv
免疫细胞OGR1在前列腺癌发生发展中的作用及其机制
基本信息
- 批准号:8843380
- 负责人:
- 金额:$ 40.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-05 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive Cell TransfersAdoptive TransferAffectAgonistB-LymphocytesBone MarrowCD8B1 geneCancer EtiologyCell LineageCell physiologyCellsCessation of lifeConditioned Culture MediaCre-LoxPDataDevelopmentEffector CellFoundationsFutureG-Protein-Coupled ReceptorsGPR68 geneGenesGoalsHumanITGAM geneImmuneImmune responseImmunotherapyIn VitroIncidenceInfiltrationKnockout MiceMalignant NeoplasmsMalignant neoplasm of prostateMediatingMolecularMusMyelogenousNatural Killer CellsNeoplasm MetastasisNude MicePhysiologicalPlayPopulationPrincipal InvestigatorReportingRoleSignal TransductionStructure of base of prostateSuppressor-Effector T-LymphocytesSystemT-Cell DepletionT-LymphocyteTestingTimeTransplantationUnited StatesUp-RegulationWild Type Mousearginasebasecancer cellcancer immunotherapycell typehuman TGFB1 proteinin vivomacrophagemenmouse modelneoplastic cellnovelprogramsresearch studytumortumor immunologytumorigenesis
项目摘要
DESCRIPTION (provided by applicant): We previously cloned a G protein coupled receptor termed OGR1 from cancer cells and generated OGR1 knockout mice (ogr1-/-). Our substantial preliminary data suggest that OGR1 plays crucial roles in immune cells, and in T cells and Gr1 and CD11b double positive (DP+) cells in particular. We hypothesize that OGR1 expression not only affects the numbers of DP+ cells, but also their functions after prostate cancer (PCa) tumor cell challenge; and DP+ cells are the major suppressor cells and T cells are the major effector cells for OGR1-depedent effects in PCa. These concepts will be tested in three Specific Aims. The main goal of this proposal is to determine the cellular and molecular mechanisms underlying the functions of OGR1 in immune cells pertinent to its role in PCa tumorigenesis and metastasis. Aim 1. Investigate the role of OGR1 in T cells in PCa tumorigenesis and metastasis by 1) determining the functions of OGR1 in T cells in vivo using T cells depletion and adoptive transfer mice; by 2) examining the effect of OGR1 depletion in specific T cell lineages using specific Cre-Lox systems in mice; and by 3) determining the time course of T cell infiltration and tumor cell eradication in ogr1-/- mice. Aim 2. Determine the role of OGR1 in Gr1 and CD11b double positive (DP+) cells in PCa tumorigenesis and metastasis by 1) determining OGR1 expression in which immune cell populations is functionally involved and required for tumor development; by 2) determining the role of OGR1 in myeloid lineage in PCa development using LysM Cre-mice; and by 3) testing whether the OGR1 effects on tumorigenesis and DP+ cells are restricted to certain cancer cells. Aim 3. Delineate molecular mechanisms underlying OGR1's role in T and DP+ cells. 1) Investigate the signaling mechanisms by which OGR1 regulates the arginase activity in DP+ cells. 2) Elucidate the mechanisms by which the TRAMP-C2 conditioned medium and/or TGF-beta1 induce up-regulation of OGR1 in immune cells. 3) Test the effects of OGR1-specific agonists/antagonists in immune cells and in vivo. 4) Determine the structural requirement in OGR1 for its functions. Our long-term goal is to develop OGR1-based novel immunotherapy for cancers.
描述(申请人提供):我们先前从癌细胞中克隆了一个称为OGR1的G蛋白偶联受体,并产生了OGR1基因敲除小鼠(OGR1-/-)。我们大量的初步数据表明,OGR1在免疫细胞,特别是T细胞,特别是Gr1和CD11b双阳性(DP+)细胞中发挥着重要作用。我们假设OGR1的表达不仅影响前列腺癌(Pca)肿瘤细胞攻击后DP+细胞的数量,而且还影响其功能;在前列腺癌中,DP+细胞是主要的抑制细胞,T细胞是OGR1抑制作用的主要效应细胞。这些概念将在三个具体目标中得到检验。这个建议的主要目的是确定OGR1在免疫细胞中潜在的功能的细胞和分子机制,与其在前列腺癌的发生和转移中的作用有关。目的1)利用T细胞缺失和过继转移小鼠体内检测OGR1在T细胞中的功能;2)利用特定的Cre-Lox系统检测OGR1缺失对特定T细胞系的影响;3)确定OGR1-/-小鼠T细胞浸润和肿瘤细胞清除的时间进程,以探讨OGR1在前列腺癌发生和转移中的作用。目的:研究OGR1在Gr1和CD11b双阳性(DP+)细胞在PCa发生和转移中的作用,方法是:1)检测OGR1的表达,其中免疫细胞参与肿瘤的发生发展;2)利用LysM CRE-小鼠确定OGR1在髓系在PCa发生中的作用;3)检测OGR1对肿瘤发生和DP+细胞的影响是否仅限于某些癌细胞。目的3.阐明OGR1‘S在T和DP+细胞中作用的分子机制。1)探讨OGR1调节DP+细胞内精氨酸酶活性的信号机制。2)阐明TRAMP-C2条件培养液和/或转化生长因子-β1诱导免疫细胞OGR1表达上调的机制。3)检测OGR1特异性激动剂/拮抗剂在免疫细胞和体内的作用。4)确定OGR1对其功能的结构要求。我们的长期目标是开发基于OGR1的新型癌症免疫疗法。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hypoxic conditions differentially regulate TAZ and YAP in cancer cells.
- DOI:10.1016/j.abb.2014.07.024
- 发表时间:2014-11-15
- 期刊:
- 影响因子:3.9
- 作者:Yan, Libo;Cai, Qingchun;Xu, Yan
- 通讯作者:Xu, Yan
The ubiquitin-CXCR4 axis plays an important role in acute lung infection-enhanced lung tumor metastasis.
- DOI:10.1158/1078-0432.ccr-13-0011
- 发表时间:2013-09-01
- 期刊:
- 影响因子:0
- 作者:Yan L;Cai Q;Xu Y
- 通讯作者:Xu Y
Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells.
- DOI:10.1038/onc.2014.264
- 发表时间:2015-06
- 期刊:
- 影响因子:8
- 作者:
- 通讯作者:
OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages.
OGR1/GPR68调节实验性自身免疫性脑脊髓炎的严重程度,并通过巨噬细胞调节一氧化氮的产生。
- DOI:10.1371/journal.pone.0148439
- 发表时间:2016
- 期刊:
- 影响因子:3.7
- 作者:D'Souza CA;Zhao FL;Li X;Xu Y;Dunn SE;Zhang L
- 通讯作者:Zhang L
Adoptive Transfer of Myeloid-Derived Suppressor Cells and T Cells in a Prostate Cancer Model.
前列腺癌模型中骨髓源性抑制细胞和 T 细胞的过继转移。
- DOI:10.21769/bioprotoc.1557
- 发表时间:2015
- 期刊:
- 影响因子:0.8
- 作者:Yan,Libo;Xu,Yan
- 通讯作者:Xu,Yan
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YAN XU其他文献
YAN XU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YAN XU', 18)}}的其他基金
Peripheral and Central Pathways of α3 Glycine Receptors as Non-Opioid Molecular Targets to Treat Pain
α3 甘氨酸受体的外周和中枢通路作为非阿片类药物分子靶点治疗疼痛
- 批准号:
10612086 - 财政年份:2022
- 资助金额:
$ 40.51万 - 项目类别:
Peripheral and Central Pathways of α3 Glycine Receptors as Non-Opioid Molecular Targets to Treat Pain
α3 甘氨酸受体的外周和中枢通路作为非阿片类药物分子靶点治疗疼痛
- 批准号:
10445387 - 财政年份:2022
- 资助金额:
$ 40.51万 - 项目类别:
Uterine signaling networks in the pathogenesis of pulmonary lymphangioleiomyomatosis (LAM)
肺淋巴管平滑肌瘤病 (LAM) 发病机制中的子宫信号网络
- 批准号:
10447086 - 财政年份:2020
- 资助金额:
$ 40.51万 - 项目类别:
Uterine signaling networks in the pathogenesis of pulmonary lymphangioleiomyomatosis (LAM)
肺淋巴管平滑肌瘤病 (LAM) 发病机制中的子宫信号网络
- 批准号:
10221045 - 财政年份:2020
- 资助金额:
$ 40.51万 - 项目类别:
Uterine signaling networks in the pathogenesis of pulmonary lymphangioleiomyomatosis (LAM)
肺淋巴管平滑肌瘤病 (LAM) 发病机制中的子宫信号网络
- 批准号:
10027128 - 财政年份:2020
- 资助金额:
$ 40.51万 - 项目类别:
Uterine signaling networks in the pathogenesis of pulmonary lymphangioleiomyomatosis (LAM)
肺淋巴管平滑肌瘤病 (LAM) 发病机制中的子宫信号网络
- 批准号:
10633293 - 财政年份:2020
- 资助金额:
$ 40.51万 - 项目类别:
Role of immune cell OGR1 in prostate cancer development and the mechanisms involv
免疫细胞OGR1在前列腺癌发生发展中的作用及其机制
- 批准号:
8296495 - 财政年份:2011
- 资助金额:
$ 40.51万 - 项目类别:














{{item.name}}会员




